Results 201 to 210 of about 12,091 (231)
Some of the next articles are maybe not open access.
Rinsho byori. The Japanese journal of clinical pathology, 2019
Representative diseases of BCR/ABL-negative myeloproliferative neoplasms (MPN) are polycythemia vera (PV), essential thrombocytosis (ET), and primary myelofibrosis (PMF). It was reported in 2005 that there is a common genetic mutation in Exon 14 of the JAK2 gene in MPN cases.
openaire +1 more source
Representative diseases of BCR/ABL-negative myeloproliferative neoplasms (MPN) are polycythemia vera (PV), essential thrombocytosis (ET), and primary myelofibrosis (PMF). It was reported in 2005 that there is a common genetic mutation in Exon 14 of the JAK2 gene in MPN cases.
openaire +1 more source
CALR mutation screening in pediatric primary myelofibrosis
Pediatric Blood & Cancer, 2014BackgroundPrimary myelofibrosis (PMF) is quite rare in children. Mutations of JAK2V617F or MPLW515K/L were absent in pediatric patients with PMF according to previous studies. Recently, mutations in calreticulin (CALR) were described in adult patients with JAK2/MPL‐unmutated PMF.
Wenbin, An +9 more
openaire +2 more sources
Not allCALRmutations are created equal
Leukemia & Lymphoma, 2015We have read with great interest the recent report by Zamora et al. [1] describing the investigation of co-occurrence of JAK2V617F and CALR mutations in primary myelofibrosis (PMF) patients.
Rong, He +6 more
openaire +2 more sources
Effects of CALR-Mutant Type and Burden on the Phenotype of Myeloproliferative Neoplasms
Diagnostics, 2022Jun Ho Jang, Yujin Han, Chul Won Jung
exaly
Reply to “Noncanonical CALR variants”
American Journal of Clinical Pathology, 2023openaire +2 more sources